Some breast cancers just go away, researchers say

Mammograms' ability to detect breast tumors has made them both a routine screening tool and the source of considerable controversy. A new study suggests that controversy won't be fading anytime soon.

The breast X-rays often find lumps that ultimately prove not to be cancer, causing, at the very least, worry among patients but sometimes leading to invasive treatment as well. Most women and their doctors understandably do not want to take a wait-and-see approach.

But now researchers say that mammograms detect some cancers that would go away on their own.

In a report published Nov. 24 in the Archives of Internal Medicine, researchers at the Norwegian Institute of Public Health compared breast cancer rates among regularly screened women (three mammograms in six years) with rates among women who had only one screening at the end of six years.

The regularly screened group had higher rates of breast cancer during that time frame than did the control group. No surprise there. But you'd think that the total number of cancers would be about the same among both groups at the end of six years. Not so.

The regularly screened group had 22% more cancers overall than did the control group. The researchers' conclusion? Some breast cancers go away on their own.

The study states:

"It appears that some breast cancers detected by repeated mammographic screening would not persist to be detectable by a single mammogram at the end of 6 years. This raises the possibility that the natural course of some screen-detected invasive breast cancers is to spontaneously regress."

Here's the full study. And here's a fact sheet from the National Cancer Institute on screening mammograms.

And from The Times' Opinion pages earlier this month: The excessive focus on mammography. It sums up, quite nicely, the well-established pitfalls of mammograms. This new study is likely to further complicate the screening and treatment picture.

-- Tami Dennis

Comments

[Susan]

This could very possibly be a study paid for by insurance companies to manipulate data in order to keep from paying for mammograms to save money. I'm just sayin'.

[sparrow]

perhaps subjecting our bodies to such screening increases the probability of creating the cancer? or, since in quantum physics we find that the potential is manifest from the possibility by the consciousness that is observing that what we focus upon grows? Regardless, in the end our bodies are indeed great healers, in time we might even start to study how we can increase this amazing ability and not to usurp it.

[Amy]

so you're suggesting that its better to take the "wait and see" approach, because SOME cancers according to ONE study MIGHT go away on their own? And getting some extras tests done is so inconvenient, that's worth risking death to take them less often? Yeah, I totally agree! I'm too lazy to go to the doctor every there years, I'd rather just hope that my cancer is the kind that goes away, thanks LA Times for posting such an important study online!

[Keith Becher]

New Treatment New Hope

Mobetron: Total Dose™ Breast Cancer Treatment

The Single Dose™ treatment is a technique using Intra Operative Electron beam Radiation Therapy (IOERT) which delivers a single dose (Treatment) of radiation at the time of surgery directly on the tumor bed. This dose is complete; no follow-up radiation is needed, saving the patient 25-30 fractions of External Beam Radiation Therapy (EBRT), which equates to elimination of 5-6 weeks of daily radiation treatments. The total dose treatment delivers in just two minutes the same effective dose of radiation as six weeks of EBRT.

There are currently two approaches to Total Dose IOERT for breast. The first was developed by the University of North Carolina (UNC) and has been used to treat over 50 women. The second was developed by the European Institute of Oncology in Milan (EIO) and has been used to treat over 2,000 women. Both institutions report excellent results.

In addition to reducing treatment and recovery timelines, Total Dose IOERT offers the exclusive benefit of oncoplastic breast reconstruction at the conclusion of the lumpectomy surgery, reducing the need for additional, post operative reconstructive surgeries. When patients are only offered conventional treatment with EBRT, some opt for mastectomy rather than breast conserving therapy (BCT), while others opt to drop the post-lumpectomy course of radiation, thus jeopardizing treatment outcome. In many cases, these decisions are made to reduce treatment timelines and the effects of prolonged radiation on healthy tissue, as well as concerns to their overall well being. Total Dose IOERT eliminates the need to schedule and allocate blocks of time for daily EBRT treatment and its effects, because it eliminates the need for EBRT, thus allowing a quick return to normal daily routines.

At EIO this technique is now so well accepted that over 1100 women have been treated with the Total Dose approach outside of the randomized trial. Representatives of the EIO have presented their results at several medical conferences; a presentation and transcript of these results, created by Professor Roberto Orecchia, M.D., Chairman of Radiation Oncology, are available for upon request.

The Total Dose technique to date has, primarily been used for what are considered low risk women; that is, they are 48 years or older, with small tumors that are no larger than 3 cm, and with no lymph node involvement.

The Mobetron is an IntraOp patented, self-shielded, mobile, electron beam linear accelerator that delivers radiation treatment to cancer patients during surgery.